Form 4: Bionano Genomics Executive Reports Share Withholding and Impact of Stock Split
SEC Filing
Jonathan V. Dixon, General Counsel of Bionano Genomics, reports the withholding of shares for tax obligations and the impact of a 1-for-60 stock split on his holdings.
Summary
- On February 15, 2025, Bionano Genomics withheld 6 shares of common stock from Jonathan V. Dixon, the General Counsel, to cover tax obligations related to the vesting of an RSU award granted on February 15, 2023.
- A 1-for-60 stock split on January 24, 2025, resulted in Dixon's ownership decreasing by 17,725 shares of common stock.
- Following these transactions, Dixon directly owns 294 shares of Bionano Genomics common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The stock split impacts all shareholders by reducing the number of outstanding shares and increasing the price per share.
Key Dates
| Date | Description |
|---|---|
| February 15, 2023 | Date of RSU award grant |
| January 24, 2025 | Date of 1-for-60 stock split |
| February 15, 2025 | Date of share withholding for tax obligations |
| February 19, 2025 | Date of Form 4 filing |
Keywords
Bionano Genomics, BNGO, Form 4, Stock Split, RSU, Share Withholding, Beneficial Ownership, Jonathan V. Dixon, General Counsel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.